PAR PHARMACEUTICALS Aktie

40,88 USD 3,3890%

Zu Ihrem Onlinebroker

kaufen verkaufen

PAR PHARMACEUTICALS Aktienkurs : 25.05. ( 15 Min. verzögert)
40,88 $ Letzter Kurs	3,39% Veränderung	39,54 $ Vortag	39,55 $ Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
41,61 - 39,43 Tag	42,80 - 24,85 52 Wochen	333.016 Tag	345.711 Ø 52 Wochen	32,88 500 Stücke	42,27 200 Stücke

PAR PHARMACEUTICALS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Deals Of The Week Jump Starts The Summer Reading List

Other testosterone gel manufacturers like Par Pharmaceuticals and Abbott have reached agreements with Watson to keep a low-cost generic off the market until at least August 2015...
22.05.

Great Value In Ancestry.com After Stock Gets Hammered

Par Pharmaceuticals Companies, Inc. (PRX – Snapshot Report) recently reported first quarter results that surprised on the Zacks Consensus by 12.3%. Even with shares soaring to 5-year highs, this Zack…

15.05.

Shoot Better Than Par With This Cheap Drug Stock

Par Pharmaceuticals Companies, Inc. (PRX – Snapshot Report) recently reported first quarter results that surprised on the Zacks Consensus by 12.3%. Even with shares soaring to 5-year highs, this Zack…
07.05.

Relational raises stake in Par Pharma to 9.9%

By Tess Stynes Relational Investors LLC raised its stake in Par Pharmaceuticals Cos. (PRX) to roughly 9.9%, as the activist investor continued to press for a sale of the company. The asset-management...
01.05.

Federal Trade Commission v. Watson Pharmaceuticals, Inc. (11th Cir. 2012)

including the ANDA filer, Paddock Pharmaceuticals and its licensee, Par Pharmaceuticals). The case involved a reverse payment settlement between NDA holder Solvay Pharmaceuticals and ANDA filers Watson Pharmaceuticals and Paddock Pharmaceuticals...